Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Linton

Showing results (281-290 of 308) with videos related to

Pageof 31
Sort By:
Diabetes & Metabolism|January 27, 2005
Genetic study of the CD36 gene in a French diabetic populationF Leprêtre, K J Linton, C Lacquemant, et al.
Protein Science : a Publication of the Protein Society|October 2, 2007
Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteinsCatherine A Martin, Emma Longman, Carol Wooding, et al.
Urology|May 12, 2004
Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancerEduardo I Canto, Herb Singh, Shahrokh F Shariat, et al.
Sleep Medicine Reviews|February 4, 2015
The effect of the work environment on future sleep disturbances: a systematic reviewSteven J Linton, Göran Kecklund, Karl A Franklin, et al.
Urology|December 15, 2004
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%Masood A Khan, Lori J Sokoll, Daniel W Chan, et al.
Medical Mycology|July 14, 2021
The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workloadAndrew M Borman, Mark Fraser, Zoe Patterson, et al.
Cancer Research|September 18, 2001
A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancerS D Mikolajczyk, K M Marker, L S Millar, et al.
Cancer Research|February 22, 2018
A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO InhibitorsMuhammad M Rahman, Allon Hazan, Joanne L Selway, et al.
Cellular and Molecular Life Sciences : CMLS|December 1, 2018
Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complexCharlotte Kawecki, Olivier Bocquet, Christian E H Schmelzer, et al.
Cancers|July 29, 2020
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to ChemotherapyAikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, et al.
Pageof 31

Showing results (281-290 of 308) with videos related to

Sort By:
Pageof 31
Diabetes & Metabolism|January 27, 2005
Genetic study of the CD36 gene in a French diabetic populationF Leprêtre, K J Linton, C Lacquemant, et al.
Protein Science : a Publication of the Protein Society|October 2, 2007
Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteinsCatherine A Martin, Emma Longman, Carol Wooding, et al.
Urology|May 12, 2004
Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancerEduardo I Canto, Herb Singh, Shahrokh F Shariat, et al.
Sleep Medicine Reviews|February 4, 2015
The effect of the work environment on future sleep disturbances: a systematic reviewSteven J Linton, Göran Kecklund, Karl A Franklin, et al.
Urology|December 15, 2004
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%Masood A Khan, Lori J Sokoll, Daniel W Chan, et al.
Medical Mycology|July 14, 2021
The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workloadAndrew M Borman, Mark Fraser, Zoe Patterson, et al.
Cancer Research|September 18, 2001
A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancerS D Mikolajczyk, K M Marker, L S Millar, et al.
Cancer Research|February 22, 2018
A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO InhibitorsMuhammad M Rahman, Allon Hazan, Joanne L Selway, et al.
Cellular and Molecular Life Sciences : CMLS|December 1, 2018
Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complexCharlotte Kawecki, Olivier Bocquet, Christian E H Schmelzer, et al.
Cancers|July 29, 2020
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to ChemotherapyAikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, et al.
Pageof 31